As the key molecules of non-classical pyroptosis pathway, the expression trend of CASP4 and CASP5 in PBMCs of patients with NSCLC was opposite to that of CASP1 in some clinical indicators. This evidence concerns the gene CASP1 and non-small cell lung carcinoma.